United Kingdom-Based Dechra Plans Boston, Massachusetts, Headquarters Operations
03/20/2026
The company’s new 28,000-square-foot global headquarters, located in the Seaport District, will be designed as a technology-enabled collaboration hub supporting its remote-first operating model. Operations are scheduled to begin by June 2026.
"As a pioneer in life sciences and innovation, Boston represents an exciting new chapter for Dechra," said Jesper Nordengaard, Dechra Chief Executive Officer, who will be based in Boston as part of the transition. "Our new headquarters will serve as a center of gravity for strategic decision-making and purposeful collaboration. The Boston ecosystem strengthens our ability to collaborate across markets, connect with partners and customers, and unlock our full growth potential."
Dechra Pharmaceuticals PLC is a veterinary pharmaceuticals company that develops, manufactures, and markets specialized medicines and products for companion animals and livestock. The company focuses on niche and underserved areas of animal health, including endocrinology, dermatology, pain management, and critical care treatments.
"Dechra's decision to locate its global headquarters in Boston underscores Massachusetts' leadership in life sciences and our ability to attract companies at the forefront of innovation. Boston offers a unique combination of talent, industry partnerships, and global connectivity that allows companies to scale and collaborate," noted Massachusetts Economic Development Secretary Eric Paley. "As a state full of caring pet owners, it's especially fitting to welcome a company dedicated to keeping our dogs, cats, and other companions healthy. We're excited to welcome Dechra to Massachusetts and look forward to supporting its work to advance veterinary specialty care and animal health worldwide."
"MassBio is pleased to welcome Dechra to Massachusetts as it establishes its global headquarters in Boston. The Commonwealth's leadership in life sciences is driven by a uniquely collaborative ecosystem that brings together industry, academia, and healthcare to advance innovation," added Kendalle Burlin O'Connell, CEO and President MassBio. "We look forward to Dechra contributing to the region's strength in translational science and helping bring new discoveries closer to real-world impact."
Project Announcements
France-Based Bel Group Expands Brookings, South Dakota, Production Operations
03/20/2026
Menco Plans Menominee County, Michigan, Operations
03/20/2026
Southern Energy Renewables Plans St. Charles Parish, Louisiana, Methanol-Aviation Fuel Operations
03/20/2026
FCH Plans West Chester, Ohio, Production Operations
03/20/2026
Schreiber Foods Expands Cumberland County, Pennsylvania, Dairy Production Operations
03/19/2026
Shamrock Technologies Expands Laurens County, South Carolina, Operations
03/19/2026
Most Read
-
Top States for Doing Business in 2024: A Continued Legacy of Excellence
Q3 2024
-
What Companies Need from Modern Manufacturing Sites
Q1 2026
-
Economic Developer Role Shifting from Deal-Making to Systems Stewardship
Q1 2026
-
Capitalizing on the OBBBA Before the 2026 Cliff
Q1 2026
-
The Skilled Trades Are Ready for a Digital Future
Q4 2025
-
Amazon’s First Mass Timber Delivery Station Tests the Future of Low-Carbon Logistics
Q4 2025
-
Last Word: Don’t Lose by Winning
Q1 2026